Literature DB >> 6441449

Evidence of circulating interferon-gamma in newly diagnosed diabetic children.

P A Tovo, F Cerutti, E Palomba, C Salomone, A Pugliese.   

Abstract

Acid-stable interferons (IFN-alpha or IFN-beta) are produced by nucleated cells infected by virus, while acid-labile interferon (IFN-gamma) is synthesized by activated T-lymphocytes. IFN-gamma or an atypical form of acid-labile IFN-alpha have been observed in the circulation of some patients with autoimmune disease. It is believed that autoimmunity and/or viral infections are involved in the pathogenesis of insulin dependent diabetes mellitus. We therefore examined the sera of newly diagnosed diabetic children for the presence of virus-induced or acid-labile IFN. Significant IFN levels (greater than or equal to 8 U/ml) were observed in 11 of 29 patients when compared to 31 healthy children in the same age range. The inhibitor is characterized by species specificity, acid-lability and neutralization with anti-serum for IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6441449     DOI: 10.1111/j.1651-2227.1984.tb17776.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  6 in total

Review 1.  Prospects for the prevention and reversal of type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky; Diego Silva; Desmond A Schatz
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM.

Authors:  M J Hussain; M Peakman; H Gallati; S S Lo; M Hawa; G C Viberti; P J Watkins; R D Leslie; D Vergani
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

Review 3.  Expression of the genes of interferons and other cytokines in normal and diseased tissues of man.

Authors:  M G Tovey
Journal:  Experientia       Date:  1989-06-15

4.  Gamma interferon prevents diabetes in the BB rat.

Authors:  D O Sobel; J Newsome
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

Review 5.  The role of immunotherapy in type I diabetes mellitus.

Authors:  M E Geffner; B M Lippe
Journal:  West J Med       Date:  1987-03

Review 6.  The potential role of interferons and interferon antagonists in inflammatory disease.

Authors:  H Heremans; A Billiau
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.